900000000000509007: United States of America English language reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Language type reference set (foundation metadata concept)\English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)\US English

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
US English	Is a	English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	acceptabilityId
Product containing precisely epoetin alfa 40000 unit/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely epoetin beta 10000 unit/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely epoetin beta 20000 unit/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely epoetin beta 50000 unit/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely epoetin theta 10000 unit/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely epoetin theta 2000 unit/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely epoetin theta 20000 unit/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely epoetin theta 30000 unit/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely epoetin theta 4000 unit/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely epoetin theta 6000 unit/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely epoetin theta 8000 unit/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ergocalciferol 1.25 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ergocalciferol 1.25 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ergocalciferol 200 microgram/1 milliliter conventional release oral solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ergometrine maleate 500 microgram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely erlotinib (as erlotinib hydrochloride) 100 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely erlotinib (as erlotinib hydrochloride) 150 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely erythromycin 5 milligram/1 gram conventional release eye ointment (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely estradiol cypionate 10 milligram/1 milliliter and medroxyprogesterone acetate 50 milligram/1 milliliter prolonged-release suspension for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely etanercept 25 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely etanercept 50 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ethambutol 100 milligram/1 each tablet for conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ethambutol hydrochloride 100 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ethambutol hydrochloride 400 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ethanol 0.7 milliliter/1 milliliter conventional release cutaneous solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ethinylestradiol 35 microgram and norethisterone 1 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ethionamide 125 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ethionamide 125 milligram/1 each tablet for conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ethionamide 250 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ethosuximide 250 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ethosuximide 50 milligram/1 milliliter conventional release oral solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely etonogestrel 68 milligram/1 each prolonged-release subcutaneous implant (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely etoposide 100 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely etoposide 20 milligram/1 milliliter conventional release solution for infusion (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely etoposide 50 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely fentanyl 100 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely fentanyl 12 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely fentanyl 25 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely fentanyl 50 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely fentanyl 75 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ferric hexacyanoferrate-II 500 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ferrous fumarate 305 milligram and folic acid 350 microgram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ferrous sulfate 125 milligram/1 milliliter conventional release oral drops (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ferrous sulfate 200 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ferrous sulfate 300 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely fexinidazole 600 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely filgrastim 300 microgram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely filgrastim 600 microgram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely fluconazole 10 milligram/1 milliliter conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely fluconazole 2 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely fluconazole 50 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely flucytosine 10 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely flucytosine 250 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely fludarabine phosphate 10 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely fludarabine phosphate 50 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely fludrocortisone acetate 100 microgram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely fluorescein sodium 10 milligram/1 milliliter conventional release eye drops (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely fluorouracil (as fluorouracil sodium) 50 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely fluorouracil 10 milligram/1 gram conventional release cutaneous cream (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely fluorouracil 5 milligram/1 gram conventional release cutaneous cream (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely fluorouracil 50 milligram/1 gram conventional release cutaneous cream (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 20 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 20 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely fluphenazine decanoate 25 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely fluvastatin (as fluvastatin sodium) 20 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely fluvastatin (as fluvastatin sodium) 40 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely fluvastatin (as fluvastatin sodium) 80 milligram/1 each prolonged-release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely folic acid 1 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely folic acid 400 microgram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely folic acid 400 microgram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely folic acid 5 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely folinic acid (as calcium folinate) 3 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely fomepizole (as fomepizole sulfate) 5 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely fomepizole 1 gram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely fosfomycin (as fosfomycin sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely fosfomycin (as fosfomycin sodium) 4 gram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely furosemide 10 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely furosemide 20 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely furosemide 4 milligram/1 milliliter conventional release oral solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely furosemide 40 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely gemcitabine (as gemcitabine hydrochloride) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely gemcitabine (as gemcitabine hydrochloride) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely gentamicin (as gentamicin sulfate) 10 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely gentamicin (as gentamicin sulfate) 3 milligram/1 milliliter conventional release eye drops (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely gentamicin (as gentamicin sulfate) 40 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely glecaprevir 100 milligram and pibrentasvir 40 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely gliclazide 30 milligram/1 each prolonged-release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely gliclazide 60 milligram/1 each prolonged-release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely gliclazide 80 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely glucagon 5 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely glucagon hydrochloride 1 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely glucose 100 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely glucose 13.5 gram and potassium chloride 1.5 gram and sodium chloride 2.6 gram and sodium citrate 2.9 gram/1 sachet powder for conventional release oral solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely glucose 40 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely glucose 50 milligram/1 milliliter and sodium chloride 9 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely glucose 50 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely glucose 500 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely glucose 75 milligram/1 milliliter and lidocaine hydrochloride 50 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)

Start Previous Page 408 of 579 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001115012	United States of America English language reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	IPS terminology module (core metadata concept)
900000000001116013	US English	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	IPS terminology module (core metadata concept)
900000000001117016	United States of America English language reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	IPS terminology module (core metadata concept)